Procter & Gamble Company PG

Chief Growth Officer Mary Beech details how work with brand consultancy Redscout turned consumer insights into campaigns and a communication style.

Kimberly-Clark has raised its dividend through every recession of the past two decades, but a $48.7 billion acquisition and free cash flow that already fell short of last year's dividend payment put that streak in genuine jeopardy.

Procter & Gamble (NYSE:PG) brand Pantene has introduced a new Cream to Mist hair product co-created with a certified trichologist and viral hair influencer. The launch centers on a cream formula that transforms into a fine mist designed to deliver intense hydration across a wide range of hair types. Pantene developed the Cream to Mist format in response to consumer feedback seeking richer nourishment from spray based conditioners and stylers. This Cream to Mist debut with a trichologist...

At a Barclays conference this month, Colgate-Palmolive and Kimberly-Clark flagged rising material and freight costs, while Procter & Gamble gave a Supply Chain 3.0 update.

Three stocks have raised their dividends for over 30 consecutive years through recessions, wars, and market crashes, and one has paid shareholders without interruption for 136 years straight. Find out which name a 65-year-old retiree should anchor their income portfolio around.

Stock Market Today: The Dow Jones index falls Monday as President Trump rejects Iran's bid to end Middle East fighting.

Capri-Sun declined to comment on the reasons for Weening's departure.

CINCINNATI, September 28, 2026--Pantene, the number one most awarded hair-care brand*, introduces the launch of Pantene Cream to Mist, its first co-created product with Abbey Yung, certified trichologist and viral hair advocate.

Clorox has raised its dividend for decades, but a cratering stock price, a payout ratio management calls elevated, and a debt load that ballooned after two major deals raise a pointed question about whether that streak survives fiscal 2027.

PK Consumer Health ("PK"), a European consumer health group comprising Lucovitaal, Puhdistamo and HealthAid, and backed by Avista Healthcare Partners, has appointed Neil Lister as Chief Executive Officer.